Please login to the form below

tropical diseases

This page shows the latest tropical diseases news and features for those working in and with pharma, biotech and healthcare.

Pfizer signs $425m flu vaccine deal with Germany’s BioNTech

number of diseases, including Zika and rabies. ... Last year, a research team from the University of Munich’s Department of Infectious Diseases and Tropical Medicine moved a rabies vaccine developed by CureVac into what it said was the

Latest news

The power of pharma businesses to drive social change

For example, we have a focus on, and commitment to, combatting neglected tropical diseases (NTDs). ... Our research teams are collaborating with peers from organisations around the world to help in the development of effective treatments for diseases
Novartis' Swiss head of operations reveals job cuts

and said it planned to move its tropical diseases research from Singapore to California.
Sanofi pays $245m for FDA priority review voucher

Gilead Sciences bought one from Canada's Knight Therapeutics last year that was awarded by the FDA in return for developing a drug for a neglected tropical disease. ... The rising price also reflects the scarcity of the vouchers, which so far are only
GSK tops pharma access to medicines table

drive to tackle neglected tropical diseases," commented ATMI founder and chief executive Wim Leereveld. ... the pipeline tackling diseases affecting developing countries to 327 at last count.
Novartis licenses tuberculosis R&D to TB Alliance

As part of the deal the TB Alliance will assume financial and operational responsibility for the continued research into potential TB treatments discovered at the Novartis Institutes for Tropical Diseases (NITD).

More from news
Approximately 4 fully matching, plus 33 partially matching documents found.

Latest Intelligence

Reaching new heights

The seemingly intractable problems of neglected tropical diseases, compounded by poverty and war in Africa, finally appear to be responding to philanthropy-funded research and engagement, resulting in fundamental changes by ... biologics. Patients will
Pharma deals in August 2015

$65m. Antisense oligonucleotides target RNA and the new collaboration will extend into renal diseases, cardiovascular and metabolic fields. ... Introduced by the FDA in 2007, a priority review voucher (PRV) is an incentive for companies to invest in
Pharma deals during November 2014

Introduced by the FDA in 2007, a PRV is an incentive for companies to invest in treatments for neglected tropical diseases. ... One of 16 tropical diseases that qualify is leishmaniasis, for which Knight's Impavido (miltefosine) was approved in March by
Interview: Charles Mgone, EDCTP

We will ask them what areas they are interested in regarding our scope in HIV, TB, malaria and now neglected tropical diseases.”. ... EDCTP offers a more cost-effective and unified means of tackling poverty-related diseases.”.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

GSK's Ellen Strahlman joins med tech firm BD

global head of neglected tropical diseases.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Associate Medical Director: Highly Competitive

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Project / Account Manager (Medical Education): Salary TBC

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Scientific Director / Editorial Team Leader: Great salary and benefits

Healthcare Communications Account Directors x 2: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Associate Editorial Director – Med Comms – London: Salary TBC

Account Director: £48, 000 - £60, 000

Events Manager – Med Comms – Surrey: Salary TBC

Director, Market Access / HEOR - North-West: Negotiable

Account Manager / Senior Account Manager: 35, 000-40, 000

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Account Manager / Account Director: Competative

Account Director: Excellent benefits

Client Services Director – Medical Education Agency – North West...: Salary TBC

Associate Director, Market Access & HEOR – North-West: Negotiable

Senior Medical Writer: Competitive Salary

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...